A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis | NEJM
Intravenous Immunoglobulin an Effective Treatment for Refractory Cutaneous Dermatomyositis – Consult QD
Intravenous immunoglobulin effective against dermatomyositis: NEJM
Improvement in Dermatomyositis Observed in Patients Given Intravenous Immune Globulin
Recommendations for IVIG use in the blue indications | Download Table
Frontiers | High-Dose Intravenous Immunoglobulin in Skin Autoimmune Disease
Infusion Therapy Treatment for Dermatomyositis - Infusion Associates
Frontiers | High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects
Off-Label Use of Intravenous Immunoglobulin (IVIG)
Consensus-based recommendations for the management of juvenile dermatomyositis | Annals of the Rheumatic Diseases
Octagam 10% Evidence - ProDERM Study in Adults with Dermatomyositis
Guidelines of the Brazilian Society of Rheumatology for the treatment of systemic autoimmune myopathies | Advances in Rheumatology | Full Text
Trial of Intravenous Immune Globulin in Dermatomyositis | NEJM
octagam®
Frontiers | High-Dose Intravenous Immunoglobulin in Skin Autoimmune Disease
IVIG a Winner for Dermatomyositis | MedPage Today
Eczematous reaction to IVIG for the treatment of dermatomyositis - ScienceDirect
PDF) Gottfried I, Seeber A, Anegg B et al.High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels. Eur J Dermatol 10:29-35 | Armin Rieger - Academia.edu
Intravenous Immunoglobulin (IVIG) Article
Intravenous Immunoglobulin (IVIG)
Octagam 10% IVIg Treatment - For Dermatomyositis in Adults
IVIg Proves Effective for Dermatomyositis in Phase 3 Trial
Development of practice and consensus-based strategies including a treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and Austria | Pediatric Rheumatology | Full Text
